# TiVi Evaluation of Microcirculatory Reactivity of the Skin to Galvanic Stimulation: Effect of Aspirin

Study · id `cardio:ct-nct03357367` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03357367](<https://clinicaltrials.gov/study/NCT03357367>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03357367

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 830 participants.

## Technical summary

Registry record NCT03357367. Allocation not applicable; no masking; primary purpose treatment. Start 2018-02-08 (actual); primary completion 2021-09-26 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 830 participants (enrolled count; ClinicalTrials.gov record NCT03357367, source copy `cardio:ctgov-nct03357367-2022-06-24`, retrieved 2026-10-31)
- Started: 2018-02-08 (actual) (ClinicalTrials.gov record NCT03357367, source copy `cardio:ctgov-nct03357367-2022-06-24`, retrieved 2026-10-31)
- Primary completion: 2021-09-26 (actual) (ClinicalTrials.gov record NCT03357367, source copy `cardio:ctgov-nct03357367-2022-06-24`, retrieved 2026-10-31)
- Completion: 2021-09-26 (actual) (ClinicalTrials.gov record NCT03357367, source copy `cardio:ctgov-nct03357367-2022-06-24`, retrieved 2026-10-31)
- Countries: France (ClinicalTrials.gov record NCT03357367, source copy `cardio:ctgov-nct03357367-2022-06-24`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03357367-2022-06-24`, retrieved 2026-10-31)

## The registry's words

- Brief title: TiVi Evaluation of Microcirculatory Reactivity of the Skin to Galvanic Stimulation: Effect of Aspirin
- Acronym: PIRAAT
- Condition: Peripheral Arterial Disease
- Intervention (Device): TiVi system
- Lead sponsor: University Hospital, Angers
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: University Hospital, Angers (`cardio:org-university-hospital-angers`)

## Provenance

Content hash: 9f42790bc3d9f9c240f497e14f03bac29dcec3c6a535d5bcee36447ca90eb8fa
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
